Treatment-associated network dynamics in patients with globus sensations: a proof-of-concept study

被引:0
|
作者
Imperiale, Marina N. [1 ]
Lieb, Roselind [1 ]
Meinlschmidt, Gunther [1 ,2 ,3 ,4 ]
机构
[1] Univ Basel, Div Clin Psychol & Epidemiol, Dept Psychol, Missionsstr 62a, CH-4055 Basel, Switzerland
[2] Int Psychoanalyt Univ IPU Berlin, Dept Clin Psychol & Cognit Behav Therapy, Stromstr 1, D-10555 Berlin, Germany
[3] Univ Hosp Basel, Dept Digital & Blended Psychosomat & Psychotherap, Hebelstr 2, CH-4031 Basel, Switzerland
[4] Univ Basel, Hebelstr 2, CH-4031 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
UNEXPLAINED PHYSICAL SYMPTOMS; SOMATOFORM DISORDERS; PSYCHOLOGICAL TREATMENT; SOMATIZATION; MANAGEMENT; COMORBIDITY; PREVALENCE; VALIDATION; PHARYNGIS; EFFICACY;
D O I
10.1038/s41598-023-42186-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this proof-of-concept study, we used a systems perspective to conceptualize and investigate treatment-related dynamics (temporal and cross-sectional associations) of symptoms and elements related to the manifestation of a common functional somatic syndrome (FSS), Globus Sensations (GS). We analyzed data from 100 patients (M=47.1 years, SD=14.4 years; 64% female) with GS who received eight sessions of group psychotherapy in the context of a randomized controlled trial (RCT). Symptoms and elements were assessed after each treatment session. We applied a multilevel graphical vector-autoregression (ml GVAR) model approach resulting in three separate, complementary networks (temporal, contemporaneous, and between-subject) for an affective, cognitive, and behavioral dimension, respectively. GS were not temporally associated with any affective, cognitive, and behavioral elements. Temporally, catastrophizing cognitions predicted bodily weakness (r=0.14, p<0.01, 95% confidence interval (CI) [0.04-0.23]) and GS predicted somatic distress (r=0.18, p<0.05, 95% CI [0.04-0.33]). Potential causal pathways between catastrophizing cognitions and bodily weakness as well as GS and somatic distress may reflect treatment-related temporal change processes in patients with GS. Our study illustrates how dynamic NA can be used in the context of outcome research.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
    Rees, Frances
    Jenkins, Wendy
    Doherty, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) : 826 - 830
  • [2] Treatment of Recurrent Eczematous External Otitis with Honey Eardrops: A Proof-of-Concept Study
    Henatsch, Darius
    Nabuurs, Cindy H.
    van de Goor, Rens M.
    Wolffs, Petra F.
    Stokroos, Robert J.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 157 (04) : 696 - 699
  • [3] Cariprazine in the treatment of schizophrenia: a proof-of-concept trial
    Durgam, Suresh
    Litman, Robert E.
    Papadakis, Kelly
    Li, Dayong
    Nemeth, Gyoergy
    Laszlovszky, Istvan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (02) : 61 - 68
  • [4] Referral to treatment for hospitalized medical patients with an alcohol use disorder: A proof-of-concept brief intervention study
    Berger, Lisa
    Hernandez-Meier, Jennifer
    Hyatt, John
    Brondino, Michael
    SOCIAL WORK IN HEALTH CARE, 2017, 56 (05) : 321 - 334
  • [5] Treatment of avoidant-restrictive food intake disorder in an older adult: A proof-of-concept case study
    Grunewald, William
    Smith, April R. R.
    Brown, Tiffany A. A.
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2023, 56 (09) : 1795 - 1800
  • [6] Proof-of-concept study of electrospun PLGA membrane in the treatment of limbal stem cell deficiency
    Ramachandran, Charanya
    Deshpande, Pallavi
    Ortega, Ilida
    Sefat, Farshid
    McKean, Rob
    Srivastava, Mala
    MacNeil, Sheila
    Basu, Sayan
    Sangwan, Virender Singh
    BMJ OPEN OPHTHALMOLOGY, 2021, 6 (01):
  • [7] Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression
    Kanes, Stephen J.
    Colquhoun, Helen
    Doherty, James
    Raines, Shane
    Hoffmann, Ethan
    Rubinow, David R.
    Meltzer-Brody, Samantha
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2017, 32 (02)
  • [8] Proof-of-concept for a novel nanotechnology-based treatment for urolithiasis
    Houlihan, Ian
    Kang, Benjamin
    Krishna, Vijay
    De, Smita
    UROLITHIASIS, 2024, 52 (01)
  • [9] Experience of Peer Bloggers Using a Social Media Website for Adolescents With Depression or Anxiety: Proof-of-Concept Study
    Karim, Sana
    Hsiung, Kimberly
    Symonds, Maria
    Radovic, Ana
    JMIR FORMATIVE RESEARCH, 2021, 5 (07)
  • [10] VeCHAT: a proof-of-concept study on screening and managing veterans' mental health and wellbeing
    Goodyear-Smith, Felicity
    Darragh, Margot
    Warren, Jim
    JOURNAL OF PRIMARY HEALTH CARE, 2021, 13 (01) : 75 - 83